Sitewide
Research aims to identify markers for menopausal women at risk for deadly blood clot
In women, hormone therapy is a risk factor for venous thrombosis, a blood clot forming deep inside the vein. Although the disorder is rare, it increases exponentially during menopause and can be deadly. Hormone trials conducted thus far, focusing on proteins in blood coagulation, have not yet led to a risk profile, precluding identification of women at risk. Mayo Clinic researchers have now developed a novel concept that uses blood platelets to define thrombotic risk.
Similar Articles On This Topic:
- Researchers identify factors associated with increased risk of blood clot within coronary stent
- Why men are more at risk of diseases caused by blood clots than women
- Location of body fat affects risk of blood clots in men, women
- Molecular imaging can identify a potentially deadly blood vessel condition, research suggests
- Researchers identify novel genetic markers linked to increased risk of heart attack
Popular Today:
Science 2.0:
- Science Can Save Crops, Forests And Endangered Animals By Doing This One Thing
- Organic Carbon In Meteorites Came From Mars
- Is That A Dragon In Your Berth Or Are You Just Happy To See Me?
- Are Anthropogenic Pressures Increasing The Speed Of Bacterial Evolution?
- From Towel Day To SpaceX And Transparency Grenades
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment